Tufts Medical Center has recruited a prominent health care quality expert to be the hospital's chief medical officer. Dr. Saul N. Weingart, vice president for quality improvement and patient safety at Dana-Farber Cancer Institute, will replace Dr. Michael Wagner, now serving as chief executive of the Tufts physician organization.
Weingart’s name “is synonymous with quality, innovation and patient safety. I am extremely pleased that his name now will also be associated with Tufts Medical Center,” Wagner said.
While practicing internal medicine at Dana-Farber, Weingart has led programs to increase patient satisfactions scores and flu vaccination among staff and a research program focused on medication safety and information technology.
Prior to his role there, he was director of patient safety in the general medicine division of Beth Israel Deaconess Medical Center. He studied medicine at the University of Rochester.
Weingart is chairman of the National Patient Safety Foundation board of governors, a member of the the patient engagement panel of the Patient-Centered Outcomes Research Institute, and a faculty member at Harvard Medical School and School of Public Health.
Weingart, who lives in Newton and begins his new role July 15, has focused his practice partly on caring for adult survivors of pediatric cancers. He will continue to see patients with Tufts General Medical Associates.